Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/6/05 → 12/4/07 |
Funding
- Barr Laboratories Inc. (DR-PSE-309)
- Duramed Pharmaceuticals, Inc. (DR-PSE-309)
Prot# DR-PSE-309: Mltctr, Opn-Lbl Study to Eval. Efficacy & Safety of Extended Cycle, Low Dose, Cmbnt'n Oral Contraceptive Regimen, DP3-Lo 84/10, Which Utilizes Ethinyl Estradiol During 7 Day Interval Bt/wn Each 84-Day Cycle of Cmbnt'n Therapy for Prevent
- Shulman, Lee P (PD/PI)
- Hammond, Cassing (Co-PD/PI)
- Luthringshausen, Michelle M (Co-PD/PI)
- Stika, Catherine Susan (Co-PD/PI)
Project: Research project